Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders-Reference-Cited by-同舟云学术

Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders

Published:2024 Issue:20 Volume:12 Page:4759-4784
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Chu Runxuan¹^ORCID,Wang Yi²^ORCID,Kong Jianglong²^ORCID,Pan Ting¹³,Yang Yani¹,He Jun¹^ORCID

Affiliation:

1. National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Shanghai 201203, P. R. China

2. Department of Chemistry, Hong Kong Baptist University, Kowloon Tung, Hong Kong SAR, P. R. China

3. Department of Pharmaceutics School of Pharmacy, China Pharmaceutical University, Nanjing 210009, P. R. China

Abstract

This paper provides a comprehensive review of the structure, composition, and applications of LNPs in the treatment of hepatic disorders and offers insights into prospects and challenges in the future development of LNPs.

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D3TB02766J

Reference254 articles.

1. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis

2. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System

3. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

4. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

5. Aromatized liposomes for sustained drug delivery

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antioxidant-related enzymes and peptides as biomarkers of metallic nanoparticles (eco)toxicity in the aquatic environment;Chemosphere;2024-09